ArticleCureus2026
Human Papillomavirus (HPV)-Associated Primary Squamous Cell Carcinoma of the Rectosigmoid Colon: A Case Report and Literature Review of a Rare Malignancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary colonic squamous cell carcinoma (SCC) represents a small minority of all colorectal cancer cases. Common clinical presentations include abdominal pain, weight loss, anorexia, dyschezia, and hematochezia. While adjuvant chemotherapy/radiation may be considered, treatment of colonic SCC is primarily surgical. We report a case of primary colonic SCC. A 66-year-old man with multiple comorbidities and a 42-pack-year smoking history presented with abdominal pain, constipation, and rectal bleeding. Colonoscopy findings included an anorectal ulcer and an ulcerated rectal mass, diagnosed as poorly differentiated, HPV-related SCC. Surgical treatment consisted of a low anterior resection with ileostomy and adjuvant chemoradiation, complicated by leukopenia/neutropenia. The ileostomy was reversed six months later with no gross malignancy. However, circulating tumor DNA (ctDNA) remained positive with a follow-up positron emission tomography scan and biopsy confirming recurrent SCC. The patient is currently receiving combination chemotherapy with carboplatin and paclitaxel, with considerations being made for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. This case demonstrates the role of ctDNA as an early marker of recurrence and an association with HPV infection. However, the risk factors for primary colonic SCC remain unclear, and adjuvant chemoradiation lacks consensus. Further evaluation of primary colonic SCC cases is necessary to determine standardized management guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.